Ocular Therapeutix Statistics

Total Valuation

FRA:0OT has a market cap or net worth of EUR 1.44 billion. The enterprise value is 877.28 million.

Market Cap	1.44B
Enterprise Value	877.28M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	217.69M
Shares Outstanding	n/a
Shares Change (YoY)	+18.31%
Shares Change (QoQ)	+21.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	215.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.49
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.87
EV / Sales	19.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.75

Financial Position

The company has a current ratio of 15.39, with a Debt / Equity ratio of 0.12.

Current Ratio	15.39
Quick Ratio	15.11
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-22.82

Financial Efficiency

Return on equity (ROE) is -54.85% and return on invested capital (ROIC) is -30.07%.

Return on Equity (ROE)	-54.85%
Return on Assets (ROA)	-26.66%
Return on Invested Capital (ROIC)	-30.07%
Return on Capital Employed (ROCE)	-35.66%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	136,144
Profits Per Employee	-696,924
Employee Count	325
Asset Turnover	0.08
Inventory Turnover	61.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.27%
50-Day Moving Average	9.42
200-Day Moving Average	9.33
Relative Strength Index (RSI)	39.02
Average Volume (20 Days)	318

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.07

Income Statement

In the last 12 months, FRA:0OT had revenue of EUR 44.25 million and -226.50 million in losses. Loss per share was -1.21.

Revenue	44.25M
Gross Profit	-129.22M
Operating Income	-229.97M
Pretax Income	-226.50M
Net Income	-226.50M
EBITDA	-226.29M
EBIT	-229.97M
Loss Per Share	-1.21

Full Income Statement

Balance Sheet

The company has 627.75 million in cash and 65.55 million in debt, with a net cash position of 562.20 million.

Cash & Cash Equivalents	627.75M
Total Debt	65.55M
Net Cash	562.20M
Net Cash Per Share	n/a
Equity (Book Value)	557.28M
Book Value Per Share	2.58
Working Capital	622.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -174.50 million and capital expenditures -10.23 million, giving a free cash flow of -184.73 million.

Operating Cash Flow	-174.50M
Capital Expenditures	-10.23M
Free Cash Flow	-184.73M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-292.04%
Operating Margin	-519.75%
Pretax Margin	-511.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0OT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.31%
Shareholder Yield	-18.31%
Earnings Yield	-15.76%
FCF Yield	-12.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0OT has an Altman Z-Score of 4.99 and a Piotroski F-Score of 2.

Altman Z-Score	4.99
Piotroski F-Score	2